Global Novel Vaccine Delivery Systems Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Novel vaccine delivery includes formulations, technologies, methods, and systems to transfer an active pharmaceutical ingredient in the body, as desired, in order to safely accomplish its therapeutic effect.
LPI (LP Information)' newest research report, the “Novel Vaccine Delivery Systems Industry Forecast” looks at past sales and reviews total world Novel Vaccine Delivery Systems sales in 2022, providing a comprehensive analysis by region and market sector of projected Novel Vaccine Delivery Systems sales for 2023 through 2029. With Novel Vaccine Delivery Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Novel Vaccine Delivery Systems industry.
This Insight Report provides a comprehensive analysis of the global Novel Vaccine Delivery Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Novel Vaccine Delivery Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Novel Vaccine Delivery Systems market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Novel Vaccine Delivery Systems and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Novel Vaccine Delivery Systems.
The global Novel Vaccine Delivery Systems market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Novel Vaccine Delivery Systems is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Novel Vaccine Delivery Systems is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Novel Vaccine Delivery Systems is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Novel Vaccine Delivery Systems players cover Altaris Capital Partners, Kindeva Drug Delivery, Becton, Dickinson,, Carl Zeiss Foundation, Gerresheimer AG, Corium International, Inovio Pharmaceuticals and Bioject Medical Technologies, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Novel Vaccine Delivery Systems market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Novel vaccine delivery includes formulations, technologies, methods, and systems to transfer an active pharmaceutical ingredient in the body, as desired, in order to safely accomplish its therapeutic effect.
LPI (LP Information)' newest research report, the “Novel Vaccine Delivery Systems Industry Forecast” looks at past sales and reviews total world Novel Vaccine Delivery Systems sales in 2022, providing a comprehensive analysis by region and market sector of projected Novel Vaccine Delivery Systems sales for 2023 through 2029. With Novel Vaccine Delivery Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Novel Vaccine Delivery Systems industry.
This Insight Report provides a comprehensive analysis of the global Novel Vaccine Delivery Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Novel Vaccine Delivery Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Novel Vaccine Delivery Systems market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Novel Vaccine Delivery Systems and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Novel Vaccine Delivery Systems.
The global Novel Vaccine Delivery Systems market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Novel Vaccine Delivery Systems is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Novel Vaccine Delivery Systems is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Novel Vaccine Delivery Systems is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Novel Vaccine Delivery Systems players cover Altaris Capital Partners, Kindeva Drug Delivery, Becton, Dickinson,, Carl Zeiss Foundation, Gerresheimer AG, Corium International, Inovio Pharmaceuticals and Bioject Medical Technologies, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Novel Vaccine Delivery Systems market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Intramuscular Delivery
- Intramuscular Delivery
- Others
- Hospitals & Clinics
- Research Institutes
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Altaris Capital Partners
- Kindeva Drug Delivery
- Becton
- Dickinson,
- Carl Zeiss Foundation
- Gerresheimer AG
- Corium International
- Inovio Pharmaceuticals
- Bioject Medical Technologies
- PharmaJet
- Retractable Technologies
- Terumo Corporation
- VAXXAS
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Novel Vaccine Delivery Systems Market Size 2018-2029
2.1.2 Novel Vaccine Delivery Systems Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Novel Vaccine Delivery Systems Segment by Type
2.2.1 Intramuscular Delivery
2.2.2 Intramuscular Delivery
2.2.3 Others
2.3 Novel Vaccine Delivery Systems Market Size by Type
2.3.1 Novel Vaccine Delivery Systems Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Novel Vaccine Delivery Systems Market Size Market Share by Type (2018-2023)
2.4 Novel Vaccine Delivery Systems Segment by Application
2.4.1 Hospitals & Clinics
2.4.2 Research Institutes
2.4.3 Others
2.5 Novel Vaccine Delivery Systems Market Size by Application
2.5.1 Novel Vaccine Delivery Systems Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Novel Vaccine Delivery Systems Market Size Market Share by Application (2018-2023)
3 NOVEL VACCINE DELIVERY SYSTEMS MARKET SIZE BY PLAYER
3.1 Novel Vaccine Delivery Systems Market Size Market Share by Players
3.1.1 Global Novel Vaccine Delivery Systems Revenue by Players (2018-2023)
3.1.2 Global Novel Vaccine Delivery Systems Revenue Market Share by Players (2018-2023)
3.2 Global Novel Vaccine Delivery Systems Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NOVEL VACCINE DELIVERY SYSTEMS BY REGIONS
4.1 Novel Vaccine Delivery Systems Market Size by Regions (2018-2023)
4.2 Americas Novel Vaccine Delivery Systems Market Size Growth (2018-2023)
4.3 APAC Novel Vaccine Delivery Systems Market Size Growth (2018-2023)
4.4 Europe Novel Vaccine Delivery Systems Market Size Growth (2018-2023)
4.5 Middle East & Africa Novel Vaccine Delivery Systems Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Novel Vaccine Delivery Systems Market Size by Country (2018-2023)
5.2 Americas Novel Vaccine Delivery Systems Market Size by Type (2018-2023)
5.3 Americas Novel Vaccine Delivery Systems Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Novel Vaccine Delivery Systems Market Size by Region (2018-2023)
6.2 APAC Novel Vaccine Delivery Systems Market Size by Type (2018-2023)
6.3 APAC Novel Vaccine Delivery Systems Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Novel Vaccine Delivery Systems by Country (2018-2023)
7.2 Europe Novel Vaccine Delivery Systems Market Size by Type (2018-2023)
7.3 Europe Novel Vaccine Delivery Systems Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Novel Vaccine Delivery Systems by Region (2018-2023)
8.2 Middle East & Africa Novel Vaccine Delivery Systems Market Size by Type (2018-2023)
8.3 Middle East & Africa Novel Vaccine Delivery Systems Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NOVEL VACCINE DELIVERY SYSTEMS MARKET FORECAST
10.1 Global Novel Vaccine Delivery Systems Forecast by Regions (2024-2029)
10.1.1 Global Novel Vaccine Delivery Systems Forecast by Regions (2024-2029)
10.1.2 Americas Novel Vaccine Delivery Systems Forecast
10.1.3 APAC Novel Vaccine Delivery Systems Forecast
10.1.4 Europe Novel Vaccine Delivery Systems Forecast
10.1.5 Middle East & Africa Novel Vaccine Delivery Systems Forecast
10.2 Americas Novel Vaccine Delivery Systems Forecast by Country (2024-2029)
10.2.1 United States Novel Vaccine Delivery Systems Market Forecast
10.2.2 Canada Novel Vaccine Delivery Systems Market Forecast
10.2.3 Mexico Novel Vaccine Delivery Systems Market Forecast
10.2.4 Brazil Novel Vaccine Delivery Systems Market Forecast
10.3 APAC Novel Vaccine Delivery Systems Forecast by Region (2024-2029)
10.3.1 China Novel Vaccine Delivery Systems Market Forecast
10.3.2 Japan Novel Vaccine Delivery Systems Market Forecast
10.3.3 Korea Novel Vaccine Delivery Systems Market Forecast
10.3.4 Southeast Asia Novel Vaccine Delivery Systems Market Forecast
10.3.5 India Novel Vaccine Delivery Systems Market Forecast
10.3.6 Australia Novel Vaccine Delivery Systems Market Forecast
10.4 Europe Novel Vaccine Delivery Systems Forecast by Country (2024-2029)
10.4.1 Germany Novel Vaccine Delivery Systems Market Forecast
10.4.2 France Novel Vaccine Delivery Systems Market Forecast
10.4.3 UK Novel Vaccine Delivery Systems Market Forecast
10.4.4 Italy Novel Vaccine Delivery Systems Market Forecast
10.4.5 Russia Novel Vaccine Delivery Systems Market Forecast
10.5 Middle East & Africa Novel Vaccine Delivery Systems Forecast by Region (2024-2029)
10.5.1 Egypt Novel Vaccine Delivery Systems Market Forecast
10.5.2 South Africa Novel Vaccine Delivery Systems Market Forecast
10.5.3 Israel Novel Vaccine Delivery Systems Market Forecast
10.5.4 Turkey Novel Vaccine Delivery Systems Market Forecast
10.5.5 GCC Countries Novel Vaccine Delivery Systems Market Forecast
10.6 Global Novel Vaccine Delivery Systems Forecast by Type (2024-2029)
10.7 Global Novel Vaccine Delivery Systems Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Altaris Capital Partners
11.1.1 Altaris Capital Partners Company Information
11.1.2 Altaris Capital Partners Novel Vaccine Delivery Systems Product Offered
11.1.3 Altaris Capital Partners Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Altaris Capital Partners Main Business Overview
11.1.5 Altaris Capital Partners Latest Developments
11.2 Kindeva Drug Delivery
11.2.1 Kindeva Drug Delivery Company Information
11.2.2 Kindeva Drug Delivery Novel Vaccine Delivery Systems Product Offered
11.2.3 Kindeva Drug Delivery Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Kindeva Drug Delivery Main Business Overview
11.2.5 Kindeva Drug Delivery Latest Developments
11.3 Becton
11.3.1 Becton Company Information
11.3.2 Becton Novel Vaccine Delivery Systems Product Offered
11.3.3 Becton Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Becton Main Business Overview
11.3.5 Becton Latest Developments
11.4 Dickinson,
11.4.1 Dickinson, Company Information
11.4.2 Dickinson, Novel Vaccine Delivery Systems Product Offered
11.4.3 Dickinson, Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Dickinson, Main Business Overview
11.4.5 Dickinson, Latest Developments
11.5 Carl Zeiss Foundation
11.5.1 Carl Zeiss Foundation Company Information
11.5.2 Carl Zeiss Foundation Novel Vaccine Delivery Systems Product Offered
11.5.3 Carl Zeiss Foundation Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Carl Zeiss Foundation Main Business Overview
11.5.5 Carl Zeiss Foundation Latest Developments
11.6 Gerresheimer AG
11.6.1 Gerresheimer AG Company Information
11.6.2 Gerresheimer AG Novel Vaccine Delivery Systems Product Offered
11.6.3 Gerresheimer AG Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Gerresheimer AG Main Business Overview
11.6.5 Gerresheimer AG Latest Developments
11.7 Corium International
11.7.1 Corium International Company Information
11.7.2 Corium International Novel Vaccine Delivery Systems Product Offered
11.7.3 Corium International Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Corium International Main Business Overview
11.7.5 Corium International Latest Developments
11.8 Inovio Pharmaceuticals
11.8.1 Inovio Pharmaceuticals Company Information
11.8.2 Inovio Pharmaceuticals Novel Vaccine Delivery Systems Product Offered
11.8.3 Inovio Pharmaceuticals Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Inovio Pharmaceuticals Main Business Overview
11.8.5 Inovio Pharmaceuticals Latest Developments
11.9 Bioject Medical Technologies
11.9.1 Bioject Medical Technologies Company Information
11.9.2 Bioject Medical Technologies Novel Vaccine Delivery Systems Product Offered
11.9.3 Bioject Medical Technologies Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Bioject Medical Technologies Main Business Overview
11.9.5 Bioject Medical Technologies Latest Developments
11.10 PharmaJet
11.10.1 PharmaJet Company Information
11.10.2 PharmaJet Novel Vaccine Delivery Systems Product Offered
11.10.3 PharmaJet Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 PharmaJet Main Business Overview
11.10.5 PharmaJet Latest Developments
11.11 Retractable Technologies
11.11.1 Retractable Technologies Company Information
11.11.2 Retractable Technologies Novel Vaccine Delivery Systems Product Offered
11.11.3 Retractable Technologies Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Retractable Technologies Main Business Overview
11.11.5 Retractable Technologies Latest Developments
11.12 Terumo Corporation
11.12.1 Terumo Corporation Company Information
11.12.2 Terumo Corporation Novel Vaccine Delivery Systems Product Offered
11.12.3 Terumo Corporation Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Terumo Corporation Main Business Overview
11.12.5 Terumo Corporation Latest Developments
11.13 VAXXAS
11.13.1 VAXXAS Company Information
11.13.2 VAXXAS Novel Vaccine Delivery Systems Product Offered
11.13.3 VAXXAS Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 VAXXAS Main Business Overview
11.13.5 VAXXAS Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Novel Vaccine Delivery Systems Market Size 2018-2029
2.1.2 Novel Vaccine Delivery Systems Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Novel Vaccine Delivery Systems Segment by Type
2.2.1 Intramuscular Delivery
2.2.2 Intramuscular Delivery
2.2.3 Others
2.3 Novel Vaccine Delivery Systems Market Size by Type
2.3.1 Novel Vaccine Delivery Systems Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Novel Vaccine Delivery Systems Market Size Market Share by Type (2018-2023)
2.4 Novel Vaccine Delivery Systems Segment by Application
2.4.1 Hospitals & Clinics
2.4.2 Research Institutes
2.4.3 Others
2.5 Novel Vaccine Delivery Systems Market Size by Application
2.5.1 Novel Vaccine Delivery Systems Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Novel Vaccine Delivery Systems Market Size Market Share by Application (2018-2023)
3 NOVEL VACCINE DELIVERY SYSTEMS MARKET SIZE BY PLAYER
3.1 Novel Vaccine Delivery Systems Market Size Market Share by Players
3.1.1 Global Novel Vaccine Delivery Systems Revenue by Players (2018-2023)
3.1.2 Global Novel Vaccine Delivery Systems Revenue Market Share by Players (2018-2023)
3.2 Global Novel Vaccine Delivery Systems Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NOVEL VACCINE DELIVERY SYSTEMS BY REGIONS
4.1 Novel Vaccine Delivery Systems Market Size by Regions (2018-2023)
4.2 Americas Novel Vaccine Delivery Systems Market Size Growth (2018-2023)
4.3 APAC Novel Vaccine Delivery Systems Market Size Growth (2018-2023)
4.4 Europe Novel Vaccine Delivery Systems Market Size Growth (2018-2023)
4.5 Middle East & Africa Novel Vaccine Delivery Systems Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Novel Vaccine Delivery Systems Market Size by Country (2018-2023)
5.2 Americas Novel Vaccine Delivery Systems Market Size by Type (2018-2023)
5.3 Americas Novel Vaccine Delivery Systems Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Novel Vaccine Delivery Systems Market Size by Region (2018-2023)
6.2 APAC Novel Vaccine Delivery Systems Market Size by Type (2018-2023)
6.3 APAC Novel Vaccine Delivery Systems Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Novel Vaccine Delivery Systems by Country (2018-2023)
7.2 Europe Novel Vaccine Delivery Systems Market Size by Type (2018-2023)
7.3 Europe Novel Vaccine Delivery Systems Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Novel Vaccine Delivery Systems by Region (2018-2023)
8.2 Middle East & Africa Novel Vaccine Delivery Systems Market Size by Type (2018-2023)
8.3 Middle East & Africa Novel Vaccine Delivery Systems Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NOVEL VACCINE DELIVERY SYSTEMS MARKET FORECAST
10.1 Global Novel Vaccine Delivery Systems Forecast by Regions (2024-2029)
10.1.1 Global Novel Vaccine Delivery Systems Forecast by Regions (2024-2029)
10.1.2 Americas Novel Vaccine Delivery Systems Forecast
10.1.3 APAC Novel Vaccine Delivery Systems Forecast
10.1.4 Europe Novel Vaccine Delivery Systems Forecast
10.1.5 Middle East & Africa Novel Vaccine Delivery Systems Forecast
10.2 Americas Novel Vaccine Delivery Systems Forecast by Country (2024-2029)
10.2.1 United States Novel Vaccine Delivery Systems Market Forecast
10.2.2 Canada Novel Vaccine Delivery Systems Market Forecast
10.2.3 Mexico Novel Vaccine Delivery Systems Market Forecast
10.2.4 Brazil Novel Vaccine Delivery Systems Market Forecast
10.3 APAC Novel Vaccine Delivery Systems Forecast by Region (2024-2029)
10.3.1 China Novel Vaccine Delivery Systems Market Forecast
10.3.2 Japan Novel Vaccine Delivery Systems Market Forecast
10.3.3 Korea Novel Vaccine Delivery Systems Market Forecast
10.3.4 Southeast Asia Novel Vaccine Delivery Systems Market Forecast
10.3.5 India Novel Vaccine Delivery Systems Market Forecast
10.3.6 Australia Novel Vaccine Delivery Systems Market Forecast
10.4 Europe Novel Vaccine Delivery Systems Forecast by Country (2024-2029)
10.4.1 Germany Novel Vaccine Delivery Systems Market Forecast
10.4.2 France Novel Vaccine Delivery Systems Market Forecast
10.4.3 UK Novel Vaccine Delivery Systems Market Forecast
10.4.4 Italy Novel Vaccine Delivery Systems Market Forecast
10.4.5 Russia Novel Vaccine Delivery Systems Market Forecast
10.5 Middle East & Africa Novel Vaccine Delivery Systems Forecast by Region (2024-2029)
10.5.1 Egypt Novel Vaccine Delivery Systems Market Forecast
10.5.2 South Africa Novel Vaccine Delivery Systems Market Forecast
10.5.3 Israel Novel Vaccine Delivery Systems Market Forecast
10.5.4 Turkey Novel Vaccine Delivery Systems Market Forecast
10.5.5 GCC Countries Novel Vaccine Delivery Systems Market Forecast
10.6 Global Novel Vaccine Delivery Systems Forecast by Type (2024-2029)
10.7 Global Novel Vaccine Delivery Systems Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Altaris Capital Partners
11.1.1 Altaris Capital Partners Company Information
11.1.2 Altaris Capital Partners Novel Vaccine Delivery Systems Product Offered
11.1.3 Altaris Capital Partners Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Altaris Capital Partners Main Business Overview
11.1.5 Altaris Capital Partners Latest Developments
11.2 Kindeva Drug Delivery
11.2.1 Kindeva Drug Delivery Company Information
11.2.2 Kindeva Drug Delivery Novel Vaccine Delivery Systems Product Offered
11.2.3 Kindeva Drug Delivery Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Kindeva Drug Delivery Main Business Overview
11.2.5 Kindeva Drug Delivery Latest Developments
11.3 Becton
11.3.1 Becton Company Information
11.3.2 Becton Novel Vaccine Delivery Systems Product Offered
11.3.3 Becton Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Becton Main Business Overview
11.3.5 Becton Latest Developments
11.4 Dickinson,
11.4.1 Dickinson, Company Information
11.4.2 Dickinson, Novel Vaccine Delivery Systems Product Offered
11.4.3 Dickinson, Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Dickinson, Main Business Overview
11.4.5 Dickinson, Latest Developments
11.5 Carl Zeiss Foundation
11.5.1 Carl Zeiss Foundation Company Information
11.5.2 Carl Zeiss Foundation Novel Vaccine Delivery Systems Product Offered
11.5.3 Carl Zeiss Foundation Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Carl Zeiss Foundation Main Business Overview
11.5.5 Carl Zeiss Foundation Latest Developments
11.6 Gerresheimer AG
11.6.1 Gerresheimer AG Company Information
11.6.2 Gerresheimer AG Novel Vaccine Delivery Systems Product Offered
11.6.3 Gerresheimer AG Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Gerresheimer AG Main Business Overview
11.6.5 Gerresheimer AG Latest Developments
11.7 Corium International
11.7.1 Corium International Company Information
11.7.2 Corium International Novel Vaccine Delivery Systems Product Offered
11.7.3 Corium International Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Corium International Main Business Overview
11.7.5 Corium International Latest Developments
11.8 Inovio Pharmaceuticals
11.8.1 Inovio Pharmaceuticals Company Information
11.8.2 Inovio Pharmaceuticals Novel Vaccine Delivery Systems Product Offered
11.8.3 Inovio Pharmaceuticals Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Inovio Pharmaceuticals Main Business Overview
11.8.5 Inovio Pharmaceuticals Latest Developments
11.9 Bioject Medical Technologies
11.9.1 Bioject Medical Technologies Company Information
11.9.2 Bioject Medical Technologies Novel Vaccine Delivery Systems Product Offered
11.9.3 Bioject Medical Technologies Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Bioject Medical Technologies Main Business Overview
11.9.5 Bioject Medical Technologies Latest Developments
11.10 PharmaJet
11.10.1 PharmaJet Company Information
11.10.2 PharmaJet Novel Vaccine Delivery Systems Product Offered
11.10.3 PharmaJet Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 PharmaJet Main Business Overview
11.10.5 PharmaJet Latest Developments
11.11 Retractable Technologies
11.11.1 Retractable Technologies Company Information
11.11.2 Retractable Technologies Novel Vaccine Delivery Systems Product Offered
11.11.3 Retractable Technologies Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Retractable Technologies Main Business Overview
11.11.5 Retractable Technologies Latest Developments
11.12 Terumo Corporation
11.12.1 Terumo Corporation Company Information
11.12.2 Terumo Corporation Novel Vaccine Delivery Systems Product Offered
11.12.3 Terumo Corporation Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Terumo Corporation Main Business Overview
11.12.5 Terumo Corporation Latest Developments
11.13 VAXXAS
11.13.1 VAXXAS Company Information
11.13.2 VAXXAS Novel Vaccine Delivery Systems Product Offered
11.13.3 VAXXAS Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 VAXXAS Main Business Overview
11.13.5 VAXXAS Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Novel Vaccine Delivery Systems Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Intramuscular Delivery
Table 3. Major Players of Intramuscular Delivery
Table 4. Major Players of Others
Table 5. Novel Vaccine Delivery Systems Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Novel Vaccine Delivery Systems Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Novel Vaccine Delivery Systems Market Size Market Share by Type (2018-2023)
Table 8. Novel Vaccine Delivery Systems Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Novel Vaccine Delivery Systems Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Novel Vaccine Delivery Systems Market Size Market Share by Application (2018-2023)
Table 11. Global Novel Vaccine Delivery Systems Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Novel Vaccine Delivery Systems Revenue Market Share by Player (2018-2023)
Table 13. Novel Vaccine Delivery Systems Key Players Head office and Products Offered
Table 14. Novel Vaccine Delivery Systems Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Novel Vaccine Delivery Systems Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Novel Vaccine Delivery Systems Market Size Market Share by Regions (2018-2023)
Table 19. Global Novel Vaccine Delivery Systems Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Novel Vaccine Delivery Systems Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Novel Vaccine Delivery Systems Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Novel Vaccine Delivery Systems Market Size Market Share by Country (2018-2023)
Table 23. Americas Novel Vaccine Delivery Systems Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Novel Vaccine Delivery Systems Market Size Market Share by Type (2018-2023)
Table 25. Americas Novel Vaccine Delivery Systems Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Novel Vaccine Delivery Systems Market Size Market Share by Application (2018-2023)
Table 27. APAC Novel Vaccine Delivery Systems Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Novel Vaccine Delivery Systems Market Size Market Share by Region (2018-2023)
Table 29. APAC Novel Vaccine Delivery Systems Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Novel Vaccine Delivery Systems Market Size Market Share by Type (2018-2023)
Table 31. APAC Novel Vaccine Delivery Systems Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Novel Vaccine Delivery Systems Market Size Market Share by Application (2018-2023)
Table 33. Europe Novel Vaccine Delivery Systems Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Novel Vaccine Delivery Systems Market Size Market Share by Country (2018-2023)
Table 35. Europe Novel Vaccine Delivery Systems Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Novel Vaccine Delivery Systems Market Size Market Share by Type (2018-2023)
Table 37. Europe Novel Vaccine Delivery Systems Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Novel Vaccine Delivery Systems Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Novel Vaccine Delivery Systems Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Novel Vaccine Delivery Systems Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Novel Vaccine Delivery Systems Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Novel Vaccine Delivery Systems Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Novel Vaccine Delivery Systems Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Novel Vaccine Delivery Systems Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Novel Vaccine Delivery Systems
Table 46. Key Market Challenges & Risks of Novel Vaccine Delivery Systems
Table 47. Key Industry Trends of Novel Vaccine Delivery Systems
Table 48. Global Novel Vaccine Delivery Systems Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Novel Vaccine Delivery Systems Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Novel Vaccine Delivery Systems Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Novel Vaccine Delivery Systems Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Altaris Capital Partners Details, Company Type, Novel Vaccine Delivery Systems Area Served and Its Competitors
Table 53. Altaris Capital Partners Novel Vaccine Delivery Systems Product Offered
Table 54. Altaris Capital Partners Novel Vaccine Delivery Systems Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Altaris Capital Partners Main Business
Table 56. Altaris Capital Partners Latest Developments
Table 57. Kindeva Drug Delivery Details, Company Type, Novel Vaccine Delivery Systems Area Served and Its Competitors
Table 58. Kindeva Drug Delivery Novel Vaccine Delivery Systems Product Offered
Table 59. Kindeva Drug Delivery Main Business
Table 60. Kindeva Drug Delivery Novel Vaccine Delivery Systems Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Kindeva Drug Delivery Latest Developments
Table 62. Becton Details, Company Type, Novel Vaccine Delivery Systems Area Served and Its Competitors
Table 63. Becton Novel Vaccine Delivery Systems Product Offered
Table 64. Becton Main Business
Table 65. Becton Novel Vaccine Delivery Systems Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Becton Latest Developments
Table 67. Dickinson, Details, Company Type, Novel Vaccine Delivery Systems Area Served and Its Competitors
Table 68. Dickinson, Novel Vaccine Delivery Systems Product Offered
Table 69. Dickinson, Main Business
Table 70. Dickinson, Novel Vaccine Delivery Systems Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Dickinson, Latest Developments
Table 72. Carl Zeiss Foundation Details, Company Type, Novel Vaccine Delivery Systems Area Served and Its Competitors
Table 73. Carl Zeiss Foundation Novel Vaccine Delivery Systems Product Offered
Table 74. Carl Zeiss Foundation Main Business
Table 75. Carl Zeiss Foundation Novel Vaccine Delivery Systems Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Carl Zeiss Foundation Latest Developments
Table 77. Gerresheimer AG Details, Company Type, Novel Vaccine Delivery Systems Area Served and Its Competitors
Table 78. Gerresheimer AG Novel Vaccine Delivery Systems Product Offered
Table 79. Gerresheimer AG Main Business
Table 80. Gerresheimer AG Novel Vaccine Delivery Systems Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Gerresheimer AG Latest Developments
Table 82. Corium International Details, Company Type, Novel Vaccine Delivery Systems Area Served and Its Competitors
Table 83. Corium International Novel Vaccine Delivery Systems Product Offered
Table 84. Corium International Main Business
Table 85. Corium International Novel Vaccine Delivery Systems Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Corium International Latest Developments
Table 87. Inovio Pharmaceuticals Details, Company Type, Novel Vaccine Delivery Systems Area Served and Its Competitors
Table 88. Inovio Pharmaceuticals Novel Vaccine Delivery Systems Product Offered
Table 89. Inovio Pharmaceuticals Main Business
Table 90. Inovio Pharmaceuticals Novel Vaccine Delivery Systems Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Inovio Pharmaceuticals Latest Developments
Table 92. Bioject Medical Technologies Details, Company Type, Novel Vaccine Delivery Systems Area Served and Its Competitors
Table 93. Bioject Medical Technologies Novel Vaccine Delivery Systems Product Offered
Table 94. Bioject Medical Technologies Main Business
Table 95. Bioject Medical Technologies Novel Vaccine Delivery Systems Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Bioject Medical Technologies Latest Developments
Table 97. PharmaJet Details, Company Type, Novel Vaccine Delivery Systems Area Served and Its Competitors
Table 98. PharmaJet Novel Vaccine Delivery Systems Product Offered
Table 99. PharmaJet Main Business
Table 100. PharmaJet Novel Vaccine Delivery Systems Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. PharmaJet Latest Developments
Table 102. Retractable Technologies Details, Company Type, Novel Vaccine Delivery Systems Area Served and Its Competitors
Table 103. Retractable Technologies Novel Vaccine Delivery Systems Product Offered
Table 104. Retractable Technologies Novel Vaccine Delivery Systems Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Retractable Technologies Main Business
Table 106. Retractable Technologies Latest Developments
Table 107. Terumo Corporation Details, Company Type, Novel Vaccine Delivery Systems Area Served and Its Competitors
Table 108. Terumo Corporation Novel Vaccine Delivery Systems Product Offered
Table 109. Terumo Corporation Main Business
Table 110. Terumo Corporation Novel Vaccine Delivery Systems Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Terumo Corporation Latest Developments
Table 112. VAXXAS Details, Company Type, Novel Vaccine Delivery Systems Area Served and Its Competitors
Table 113. VAXXAS Novel Vaccine Delivery Systems Product Offered
Table 114. VAXXAS Main Business
Table 115. VAXXAS Novel Vaccine Delivery Systems Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. VAXXAS Latest Developments
Table 1. Novel Vaccine Delivery Systems Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Intramuscular Delivery
Table 3. Major Players of Intramuscular Delivery
Table 4. Major Players of Others
Table 5. Novel Vaccine Delivery Systems Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Novel Vaccine Delivery Systems Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Novel Vaccine Delivery Systems Market Size Market Share by Type (2018-2023)
Table 8. Novel Vaccine Delivery Systems Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Novel Vaccine Delivery Systems Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Novel Vaccine Delivery Systems Market Size Market Share by Application (2018-2023)
Table 11. Global Novel Vaccine Delivery Systems Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Novel Vaccine Delivery Systems Revenue Market Share by Player (2018-2023)
Table 13. Novel Vaccine Delivery Systems Key Players Head office and Products Offered
Table 14. Novel Vaccine Delivery Systems Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Novel Vaccine Delivery Systems Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Novel Vaccine Delivery Systems Market Size Market Share by Regions (2018-2023)
Table 19. Global Novel Vaccine Delivery Systems Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Novel Vaccine Delivery Systems Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Novel Vaccine Delivery Systems Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Novel Vaccine Delivery Systems Market Size Market Share by Country (2018-2023)
Table 23. Americas Novel Vaccine Delivery Systems Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Novel Vaccine Delivery Systems Market Size Market Share by Type (2018-2023)
Table 25. Americas Novel Vaccine Delivery Systems Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Novel Vaccine Delivery Systems Market Size Market Share by Application (2018-2023)
Table 27. APAC Novel Vaccine Delivery Systems Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Novel Vaccine Delivery Systems Market Size Market Share by Region (2018-2023)
Table 29. APAC Novel Vaccine Delivery Systems Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Novel Vaccine Delivery Systems Market Size Market Share by Type (2018-2023)
Table 31. APAC Novel Vaccine Delivery Systems Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Novel Vaccine Delivery Systems Market Size Market Share by Application (2018-2023)
Table 33. Europe Novel Vaccine Delivery Systems Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Novel Vaccine Delivery Systems Market Size Market Share by Country (2018-2023)
Table 35. Europe Novel Vaccine Delivery Systems Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Novel Vaccine Delivery Systems Market Size Market Share by Type (2018-2023)
Table 37. Europe Novel Vaccine Delivery Systems Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Novel Vaccine Delivery Systems Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Novel Vaccine Delivery Systems Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Novel Vaccine Delivery Systems Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Novel Vaccine Delivery Systems Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Novel Vaccine Delivery Systems Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Novel Vaccine Delivery Systems Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Novel Vaccine Delivery Systems Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Novel Vaccine Delivery Systems
Table 46. Key Market Challenges & Risks of Novel Vaccine Delivery Systems
Table 47. Key Industry Trends of Novel Vaccine Delivery Systems
Table 48. Global Novel Vaccine Delivery Systems Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Novel Vaccine Delivery Systems Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Novel Vaccine Delivery Systems Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Novel Vaccine Delivery Systems Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Altaris Capital Partners Details, Company Type, Novel Vaccine Delivery Systems Area Served and Its Competitors
Table 53. Altaris Capital Partners Novel Vaccine Delivery Systems Product Offered
Table 54. Altaris Capital Partners Novel Vaccine Delivery Systems Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Altaris Capital Partners Main Business
Table 56. Altaris Capital Partners Latest Developments
Table 57. Kindeva Drug Delivery Details, Company Type, Novel Vaccine Delivery Systems Area Served and Its Competitors
Table 58. Kindeva Drug Delivery Novel Vaccine Delivery Systems Product Offered
Table 59. Kindeva Drug Delivery Main Business
Table 60. Kindeva Drug Delivery Novel Vaccine Delivery Systems Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Kindeva Drug Delivery Latest Developments
Table 62. Becton Details, Company Type, Novel Vaccine Delivery Systems Area Served and Its Competitors
Table 63. Becton Novel Vaccine Delivery Systems Product Offered
Table 64. Becton Main Business
Table 65. Becton Novel Vaccine Delivery Systems Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Becton Latest Developments
Table 67. Dickinson, Details, Company Type, Novel Vaccine Delivery Systems Area Served and Its Competitors
Table 68. Dickinson, Novel Vaccine Delivery Systems Product Offered
Table 69. Dickinson, Main Business
Table 70. Dickinson, Novel Vaccine Delivery Systems Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Dickinson, Latest Developments
Table 72. Carl Zeiss Foundation Details, Company Type, Novel Vaccine Delivery Systems Area Served and Its Competitors
Table 73. Carl Zeiss Foundation Novel Vaccine Delivery Systems Product Offered
Table 74. Carl Zeiss Foundation Main Business
Table 75. Carl Zeiss Foundation Novel Vaccine Delivery Systems Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Carl Zeiss Foundation Latest Developments
Table 77. Gerresheimer AG Details, Company Type, Novel Vaccine Delivery Systems Area Served and Its Competitors
Table 78. Gerresheimer AG Novel Vaccine Delivery Systems Product Offered
Table 79. Gerresheimer AG Main Business
Table 80. Gerresheimer AG Novel Vaccine Delivery Systems Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Gerresheimer AG Latest Developments
Table 82. Corium International Details, Company Type, Novel Vaccine Delivery Systems Area Served and Its Competitors
Table 83. Corium International Novel Vaccine Delivery Systems Product Offered
Table 84. Corium International Main Business
Table 85. Corium International Novel Vaccine Delivery Systems Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Corium International Latest Developments
Table 87. Inovio Pharmaceuticals Details, Company Type, Novel Vaccine Delivery Systems Area Served and Its Competitors
Table 88. Inovio Pharmaceuticals Novel Vaccine Delivery Systems Product Offered
Table 89. Inovio Pharmaceuticals Main Business
Table 90. Inovio Pharmaceuticals Novel Vaccine Delivery Systems Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Inovio Pharmaceuticals Latest Developments
Table 92. Bioject Medical Technologies Details, Company Type, Novel Vaccine Delivery Systems Area Served and Its Competitors
Table 93. Bioject Medical Technologies Novel Vaccine Delivery Systems Product Offered
Table 94. Bioject Medical Technologies Main Business
Table 95. Bioject Medical Technologies Novel Vaccine Delivery Systems Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Bioject Medical Technologies Latest Developments
Table 97. PharmaJet Details, Company Type, Novel Vaccine Delivery Systems Area Served and Its Competitors
Table 98. PharmaJet Novel Vaccine Delivery Systems Product Offered
Table 99. PharmaJet Main Business
Table 100. PharmaJet Novel Vaccine Delivery Systems Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. PharmaJet Latest Developments
Table 102. Retractable Technologies Details, Company Type, Novel Vaccine Delivery Systems Area Served and Its Competitors
Table 103. Retractable Technologies Novel Vaccine Delivery Systems Product Offered
Table 104. Retractable Technologies Novel Vaccine Delivery Systems Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Retractable Technologies Main Business
Table 106. Retractable Technologies Latest Developments
Table 107. Terumo Corporation Details, Company Type, Novel Vaccine Delivery Systems Area Served and Its Competitors
Table 108. Terumo Corporation Novel Vaccine Delivery Systems Product Offered
Table 109. Terumo Corporation Main Business
Table 110. Terumo Corporation Novel Vaccine Delivery Systems Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Terumo Corporation Latest Developments
Table 112. VAXXAS Details, Company Type, Novel Vaccine Delivery Systems Area Served and Its Competitors
Table 113. VAXXAS Novel Vaccine Delivery Systems Product Offered
Table 114. VAXXAS Main Business
Table 115. VAXXAS Novel Vaccine Delivery Systems Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. VAXXAS Latest Developments
LIST OF FIGURES
Figure 1. Novel Vaccine Delivery Systems Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Novel Vaccine Delivery Systems Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Novel Vaccine Delivery Systems Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Novel Vaccine Delivery Systems Sales Market Share by Country/Region (2022)
Figure 8. Novel Vaccine Delivery Systems Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Novel Vaccine Delivery Systems Market Size Market Share by Type in 2022
Figure 10. Novel Vaccine Delivery Systems in Hospitals & Clinics
Figure 11. Global Novel Vaccine Delivery Systems Market: Hospitals & Clinics (2018-2023) & ($ Millions)
Figure 12. Novel Vaccine Delivery Systems in Research Institutes
Figure 13. Global Novel Vaccine Delivery Systems Market: Research Institutes (2018-2023) & ($ Millions)
Figure 14. Novel Vaccine Delivery Systems in Others
Figure 15. Global Novel Vaccine Delivery Systems Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Novel Vaccine Delivery Systems Market Size Market Share by Application in 2022
Figure 17. Global Novel Vaccine Delivery Systems Revenue Market Share by Player in 2022
Figure 18. Global Novel Vaccine Delivery Systems Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Novel Vaccine Delivery Systems Market Size 2018-2023 ($ Millions)
Figure 20. APAC Novel Vaccine Delivery Systems Market Size 2018-2023 ($ Millions)
Figure 21. Europe Novel Vaccine Delivery Systems Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Novel Vaccine Delivery Systems Market Size 2018-2023 ($ Millions)
Figure 23. Americas Novel Vaccine Delivery Systems Value Market Share by Country in 2022
Figure 24. United States Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Novel Vaccine Delivery Systems Market Size Market Share by Region in 2022
Figure 29. APAC Novel Vaccine Delivery Systems Market Size Market Share by Type in 2022
Figure 30. APAC Novel Vaccine Delivery Systems Market Size Market Share by Application in 2022
Figure 31. China Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Novel Vaccine Delivery Systems Market Size Market Share by Country in 2022
Figure 38. Europe Novel Vaccine Delivery Systems Market Size Market Share by Type (2018-2023)
Figure 39. Europe Novel Vaccine Delivery Systems Market Size Market Share by Application (2018-2023)
Figure 40. Germany Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Novel Vaccine Delivery Systems Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Novel Vaccine Delivery Systems Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Novel Vaccine Delivery Systems Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 54. APAC Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 55. Europe Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 57. United States Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 58. Canada Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 61. China Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 62. Japan Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 63. Korea Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 65. India Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 66. Australia Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 67. Germany Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 68. France Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 69. UK Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 70. Italy Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 71. Russia Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 72. Spain Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 75. Israel Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 78. Global Novel Vaccine Delivery Systems Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Novel Vaccine Delivery Systems Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Novel Vaccine Delivery Systems Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Novel Vaccine Delivery Systems Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Novel Vaccine Delivery Systems Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Novel Vaccine Delivery Systems Sales Market Share by Country/Region (2022)
Figure 8. Novel Vaccine Delivery Systems Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Novel Vaccine Delivery Systems Market Size Market Share by Type in 2022
Figure 10. Novel Vaccine Delivery Systems in Hospitals & Clinics
Figure 11. Global Novel Vaccine Delivery Systems Market: Hospitals & Clinics (2018-2023) & ($ Millions)
Figure 12. Novel Vaccine Delivery Systems in Research Institutes
Figure 13. Global Novel Vaccine Delivery Systems Market: Research Institutes (2018-2023) & ($ Millions)
Figure 14. Novel Vaccine Delivery Systems in Others
Figure 15. Global Novel Vaccine Delivery Systems Market: Others (2018-2023) & ($ Millions)
Figure 16. Global Novel Vaccine Delivery Systems Market Size Market Share by Application in 2022
Figure 17. Global Novel Vaccine Delivery Systems Revenue Market Share by Player in 2022
Figure 18. Global Novel Vaccine Delivery Systems Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Novel Vaccine Delivery Systems Market Size 2018-2023 ($ Millions)
Figure 20. APAC Novel Vaccine Delivery Systems Market Size 2018-2023 ($ Millions)
Figure 21. Europe Novel Vaccine Delivery Systems Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Novel Vaccine Delivery Systems Market Size 2018-2023 ($ Millions)
Figure 23. Americas Novel Vaccine Delivery Systems Value Market Share by Country in 2022
Figure 24. United States Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Novel Vaccine Delivery Systems Market Size Market Share by Region in 2022
Figure 29. APAC Novel Vaccine Delivery Systems Market Size Market Share by Type in 2022
Figure 30. APAC Novel Vaccine Delivery Systems Market Size Market Share by Application in 2022
Figure 31. China Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Novel Vaccine Delivery Systems Market Size Market Share by Country in 2022
Figure 38. Europe Novel Vaccine Delivery Systems Market Size Market Share by Type (2018-2023)
Figure 39. Europe Novel Vaccine Delivery Systems Market Size Market Share by Application (2018-2023)
Figure 40. Germany Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Novel Vaccine Delivery Systems Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Novel Vaccine Delivery Systems Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Novel Vaccine Delivery Systems Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Novel Vaccine Delivery Systems Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 54. APAC Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 55. Europe Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 57. United States Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 58. Canada Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 61. China Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 62. Japan Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 63. Korea Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 65. India Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 66. Australia Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 67. Germany Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 68. France Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 69. UK Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 70. Italy Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 71. Russia Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 72. Spain Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 75. Israel Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Novel Vaccine Delivery Systems Market Size 2024-2029 ($ Millions)
Figure 78. Global Novel Vaccine Delivery Systems Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Novel Vaccine Delivery Systems Market Size Market Share Forecast by Application (2024-2029)
